Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term efficacy of subcutaneous Pangramin PLUS Dermatophagoides pteronyssinus for allergic asthma
2005-005636-28Phase 4Completed
- Sponsor
- ALK-Abelló
- Start
- Jun 2006
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dermatophagoides pteronyssinus extract in allergic asthma (2 arms), sponsored by ALK-Abelló. Primary endpoint: Primary efficacy endpoint. Started Jun 2006; status: completed.
02
Drugs
dermatophagoides pteronyssinus extract
03
Conditions
allergic asthma
Beyond the preview
Go deeper on 2005-005636-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005636-28.